Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 3/2012

Ausgabe 3/2012

Inhaltsverzeichnis ( 28 Artikel )

01.03.2012 | Original Article | Ausgabe 3/2012

Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice

Selwyn J. Hurwitz, Hongzheng Zhang, Sujin Yun, Thil D. Batuwangala, Michael Steward, Steve D. Holmes, Daniel Rycroft, Lin Pan, Mourad Tighiouart, Hyung Ju C. Shin, Lydia Koenig, Yuxiang Wang, Zhuo (Georgia) Chen, Dong M. Shin

01.03.2012 | Original Article | Ausgabe 3/2012

A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors

Matthew G. Fury, Eric Sherman, Sofia Haque, Susan Korte, Donna Lisa, Ronglai Shen, Nian Wu, David Pfister

01.03.2012 | Original Article | Ausgabe 3/2012

Evaluation of a formula for individual dosage of nedaplatin based on renal function

Shinya Sato, Hiroyuki Fujiwara, Tetsuro Oishi, Muneaki Shimada, Shizuo Machida, Yuji Takei, Hiroaki Itamochi, Mitsuaki Suzuki, Junzo Kigawa

01.03.2012 | Original Article | Ausgabe 3/2012

An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic function

Cindy L. O’Bryant, Paul Haluska, Lee Rosen, Ramesh K. Ramanathan, Balaji Venugopal, Stephen Leong, Ramesh Boinpally, Amy Franke, Karsten Witt, Jeffry Evans, Chandra Belani, S. Gail Eckhardt, Suresh Ramalingam

01.03.2012 | Original Article | Ausgabe 3/2012

Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy

Christian H. Brandts, Christiane Schulz, Normann Willich, Björn Steffen, Jendrik Hardes, Georg Gosheger, Winfried Winkelmann, Hubert Serve, Achim Heinecke, Wolfgang E. Berdel, Michael Thomas

01.03.2012 | Original Article | Ausgabe 3/2012

Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells

Pei-Ming Chu, Li-Hsin Chen, Ming-Teh Chen, Hsin-I Ma, Tsann-Long Su, Pei-Chen Hsieh, Chian-Shiu Chien, Bo-Hua Jiang, Yu-Chih Chen, Yi-Hui Lin, Yang-Hsin Shih, Pang-Hsien Tu, Shih-Hwa Chiou

01.03.2012 | Original Article | Ausgabe 3/2012

Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma

Eun Mi Lee, Sun Young Rha, Jeeyun Lee, Kyong Hwa Park, Jin-Hee Ahn

01.03.2012 | Original Article | Ausgabe 3/2012

Pharmacokinetics of TH-302: a hypoxically activated prodrug of bromo-isophosphoramide mustard in mice, rats, dogs and monkeys

Donald Jung, Lin Lin, Hailong Jiao, Xiaohong Cai, Jian-Xin Duan, M. Matteucci

01.03.2012 | Original Article | Ausgabe 3/2012

Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data

Dong Hoe Koo, Seung-Il Park, Yong-Hee Kim, Jong Hoon Kim, Hwoon-Yong Jung, Gin-Hyug Lee, Kee Don Choi, Ho June Song, Ho Young Song, Ji Hoon Shin, Kyung-Ja Cho, Dok-Hyun Yoon, Sung-Bae Kim

01.03.2012 | Original Article | Ausgabe 3/2012

Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells

C. L. King, S. Ramachandran, S. G. Chaney, L. Collins, J. A. Swenberg, K. E. deKrafft, W. Lin, L. Cicurel, M. Barbier

01.03.2012 | Original Article | Ausgabe 3/2012

Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice

Liu Zhongfa, Ming Chiu, Jiang Wang, Wei Chen, Winston Yen, Patty Fan-Havard, Lisa D. Yee, Kenneth K. Chan

01.03.2012 | Original Article | Ausgabe 3/2012

The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue

Patrizia Chiusolo, Sabrina Giammarco, Silvia Bellesi, Elisabetta Metafuni, Nicola Piccirillo, Daniela De Ritis, Sara Marietti, Sorà Federica, Luca Laurenti, Luana Fianchi, Stefan Hohaus, Leone Giuseppe, Simona Sica

01.03.2012 | Original Article | Ausgabe 3/2012

In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues

Caroline Haglund, Anna Åleskog, Peter Nygren, Joachim Gullbo, Martin Höglund, Malin Wickström, Rolf Larsson, Elin Lindhagen

01.03.2012 | Original Article | Ausgabe 3/2012 Open Access

A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer

L. Q. M. Chow, N. Blais, D. J. Jonker, S. A. Laurie, S. G. Diab, C. Canil, M. McWilliam, A. Thall, A. Ruiz-Garcia, K. Zhang, L. Tye, R. C. Chao, D. R. Camidge

01.03.2012 | Original Article | Ausgabe 3/2012

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP

Wei Zhu, Huaguo Xu, DanXia Zhu, Hui Zhi, Tongshan Wang, Jian Wang, Binghua Jiang, Yongqian Shu, Ping Liu

01.03.2012 | Original Article | Ausgabe 3/2012

First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer

Vincent Chung, Elisabeth I. Heath, William R. Schelman, Brendan M. Johnson, Lyndon C. Kirby, Kerlin M. Lynch, Jeffrey D. Botbyl, Thomas A. Lampkin, Kyle D. Holen

01.03.2012 | Original Article | Ausgabe 3/2012

A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer

M. G. Fakih, A. Groman, J. McMahon, G. Wilding, J. R. Muindi

01.03.2012 | Original Article | Ausgabe 3/2012

Effect of food and a proton pump inhibitor on the pharmacokinetics of S-1 following oral administration of S-1 in patients with advanced solid tumors

Max E. Scheulen, Kaku Saito, Ralf A. Hilger, Bastian Mende, Christopher Zergebel, Dirk Strumberg

01.03.2012 | Original Article | Ausgabe 3/2012

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

Emmanuel S. Antonarakis, Michael A. Carducci, Mario A. Eisenberger, Samuel R. Denmeade, Susan F. Slovin, Kathy Jelaca-Maxwell, Martha E. Vincent, Howard I. Scher, Michael J. Morris

01.03.2012 | Original Article | Ausgabe 3/2012

Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma

Iacopo Petrini, Monica Lencioni, Miriam Ricasoli, Mauro Iannopollo, Cinzia Orlandini, Filippo Oliveri, Carlo Bartolozzi, Sergio Ricci

01.03.2012 | Original Article | Ausgabe 3/2012

Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis

Giuseppe Lombardi, Maria Ornella Nicoletto, Milena Gusella, Pasquale Fiduccia, Maurizia Dalla Palma, Andrea Zuin, Davide Fiore, Martin Donach, Vittorina Zagonel

01.03.2012 | Original Article | Ausgabe 3/2012 Open Access

Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects

Nianhang Chen, Lian Wen, Henry Lau, Sekhar Surapaneni, Gondi Kumar

01.03.2012 | Original Article | Ausgabe 3/2012

ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein

Guan Wang, Yao Zhan, Haiqing Wang, Wenhua Li

01.03.2012 | Original Article | Ausgabe 3/2012

Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX

T. Mazard, M. Ychou, S. Thezenas, S. Poujol, F. Pinguet, A. Thirion, J. P. Bleuse, F. Portales, E. Samalin, E. Assenat

01.03.2012 | Clinical Trial Report | Ausgabe 3/2012

A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)

Heather A. Wakelee, Gary Middleton, David Dunlop, Rodryg Ramlau, Natasha Leighl, Desiree Hao, Arturo Lopez-Anaya, Petr Zatloukal, Charlotte D. Jacobs

01.03.2012 | Clinical Trial Report | Ausgabe 3/2012

A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

Jordi Rodon, Charlotte D. Jacobs, Quincy Chu, Eric K. Rowinsky, Arturo Lopez-Anaya, Chris H. Takimoto, Heather A. Wakelee

01.03.2012 | Clinical Trial Report | Ausgabe 3/2012

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study

Joseph Chao, Timothy W. Synold, Robert J. Morgan Jr., Charles Kunos, Jeff Longmate, Heinz-Josef Lenz, Dean Lim, Stephen Shibata, Vincent Chung, Ronald G. Stoller, Chandra P. Belani, David R. Gandara, Mark McNamara, Barbara J. Gitlitz, Derick H. Lau, Suresh S. Ramalingam, Angela Davies, Igor Espinoza-Delgado, Edward M. Newman, Yun Yen

01.03.2012 | Short Communication | Ausgabe 3/2012

Pharmacokinetics of carboplatin in a hemodialysis patient with small-cell lung cancer

Mikako Hiraike, Yoichi Hiraki, Nobuhiro Misumi, Kiyonori Hanada, Yasuhiro Tsuji, Hidetoshi Kamimura, Yoshiharu Karube, Kosuke Kashiwabara

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise